The Cancer Prevention and Research Institute of Texas (CPRIT) recently granted 101 awards totaling upwards of $107 million in funding to support cancer-related projects. Two grants were earmarked for product development programs, 15 grants to prevention programs, and 84 grants to research programs. After reviewing 600 grant applications, CPRIT announced the winners from institutions and organizations across the state.
“CPRIT funds provide needed support for individuals and organizations working to reduce the burden of cancer,” said Wayne Roberts, CPRIT’s chief executive officer. “Through our merit-based peer review, we identify a wide range of high-quality, innovative projects that positively impact the lives of Texans, both now and into the future. These new grants, plus the more than $970 million CPRIT has already invested in research, prevention and product development projects, will make new discoveries to cure and prevent cancer a reality.”
Highly qualified cancer researchers, prevention initiatives, and product development projects are the target of the grants from CPRIT, as outlined by the organization’s Oversight Committee. The first set of grants, totaling approximately $76.2 million, was given to eight cancer scientists and clinicians working at academic institutions in Texas. The scientists were chosen for being “promising researchers pursuing faculty appointment, outstanding early-stage researchers, and senior research faculty with distinguished professional careers and established cancer research programs,” according to a CPRIT press release.
76 other research grants will support innovative research projects that are thought to significantly advance knowledge of the causes, prevention, and treatment of cancer. The prevention awards, on the other hand, will grant $17.5 million to novel research projects working on preventing cancer for underserved populations in Texas.
“The projects receiving evidence-based grants will address increasing HPV vaccination rates, tobacco cessation in young adult smokers and increasing access to colorectal cancer screening. The projects receiving competitive continuation grants will provide screening, diagnostic and vaccination services for breast, cervical, colorectal and other cancers. Additional competitive continuation grants support public and professional education projects,” according to the press release.
In the area of product development, CPRIT will assign about $13.5 million to a Texas-based company and the relocation of an existing cancer-focused company to Texas, which are working on projects that are expected to offer breakthroughs in the treatment of brain cancer treatments, as well as in the improvement of imaging and diagnostic techniques.